Substance P Drives Inflammation in the Opposite Eye After Cataract Surgery in Diabetic Patients
Diabetic patients showed significant Substance P and inflammatory marker increases in the unoperated eye after first-eye cataract surgery.
Quick Facts
What This Study Found
In diabetic patients, Substance P (SP) and MCP-1 levels both rose significantly in the contralateral (opposite) eye after the first cataract surgery, whether the second surgery was 1 day or 1 week later (P ≤ 0.040). The SP increase in diabetic patients was significantly higher than in non-diabetic patients (P ≤ 0.030) at both time intervals.
MCP-1, a protein that attracts immune cells, also increased more in diabetic patients, reaching statistical significance in the 1-week interval group (P = 0.042).
This suggests that surgery on one eye triggers a sympathetic inflammatory response in the other eye, and diabetes amplifies this response. This may explain why diabetic patients often report more pain during their second eye surgery.
Key Numbers
51 patients; SP increase P≤0.030 diabetic vs non-diabetic; MCP-1 increase P=0.042 at 1-week interval
How They Did This
A prospective randomized clinical study with 51 cataract patients: 22 with type 2 diabetes and 29 without. Patients were randomized to have their second eye surgery at either 1-day or 1-week intervals. Aqueous humor (eye fluid) samples of more than 100 microliters were collected before each surgery. Researchers measured 10 inflammatory markers plus Substance P using Luminex assays and ELISA.
Why This Research Matters
Cataract surgery is one of the most common surgeries worldwide. Many patients need both eyes done. This study reveals that diabetic patients mount an inflammatory response in the unoperated eye, driven by Substance P. Understanding this mechanism could lead to better pain management and timing strategies for sequential cataract surgeries in diabetic patients.
The Bigger Picture
Cataract surgery is one of the most common surgeries worldwide. Understanding that diabetic patients mount a cross-eye inflammatory response could change how surgeons time bilateral procedures and manage postoperative inflammation in this large patient population.
What This Study Doesn't Tell Us
The sample size of 51 patients is modest, especially when split into four subgroups (diabetic/non-diabetic crossed with 1-day/1-week). The study only measured two time intervals, so the full time course of the inflammatory response is unknown. The mechanism connecting surgery on one eye to SP release in the other was not directly tested.
Questions This Raises
- ?Would anti-Substance P treatments before the second surgery reduce pain and inflammation?
- ?Is there an optimal waiting period between eyes that minimizes the inflammatory response?
- ?Do other neuropeptides contribute to this cross-eye effect?
Trust & Context
- Key Stat:
- 51 patients showed that diabetic patients had significantly higher cross-eye inflammation after cataract surgery
- Evidence Grade:
- Moderate evidence from a prospective randomized clinical study. Small but well-designed, with clear statistical significance for the key findings.
- Study Age:
- Published in 2020. This finding has implications for surgical planning that may already be influencing clinical practice.
- Original Title:
- Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.
- Published In:
- BMC ophthalmology, 20(1), 339 (2020)
- Authors:
- Gong, Xianhui, Ren, Yueping, Fang, Xiuxiu, Cai, Junyong, Song, E
- Database ID:
- RPEP-04821
Evidence Hierarchy
Frequently Asked Questions
Why does cataract surgery in one eye affect the other eye?
The nervous system connects both eyes. Surgery triggers nerve signals that release Substance P in the opposite eye, causing inflammation — a response amplified in diabetic patients.
Should diabetic patients wait longer between cataract surgeries?
This study suggests it may help, but more research is needed to determine the optimal timing. Talk to your surgeon about your diabetes status before scheduling bilateral procedures.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04821APA
Gong, Xianhui; Ren, Yueping; Fang, Xiuxiu; Cai, Junyong; Song, E. (2020). Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.. BMC ophthalmology, 20(1), 339. https://doi.org/10.1186/s12886-020-01598-4
MLA
Gong, Xianhui, et al. "Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.." BMC ophthalmology, 2020. https://doi.org/10.1186/s12886-020-01598-4
RethinkPeptides
RethinkPeptides Research Database. "Substance P induces sympathetic immune response in the contr..." RPEP-04821. Retrieved from https://rethinkpeptides.com/research/gong-2020-substance-p-induces-sympathetic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.